LAG3 and colorectal carcinoma: Since LAG-3 was predominantly expressed in patients with CRC in our study and LAG-3 has been regarded as an important prognostic factor, LAG-3 should be regarded as a potential therapeutic target for the treatment of CRC [49] (Table 5).